DK174931B1 - Lægemiddel med langsom frigivelse af den aktive bestanddel - Google Patents

Lægemiddel med langsom frigivelse af den aktive bestanddel Download PDF

Info

Publication number
DK174931B1
DK174931B1 DK198703731A DK373187A DK174931B1 DK 174931 B1 DK174931 B1 DK 174931B1 DK 198703731 A DK198703731 A DK 198703731A DK 373187 A DK373187 A DK 373187A DK 174931 B1 DK174931 B1 DK 174931B1
Authority
DK
Denmark
Prior art keywords
active ingredient
release drug
slow release
drug
sustained
Prior art date
Application number
DK198703731A
Other languages
Danish (da)
English (en)
Other versions
DK373187A (da
DK373187D0 (da
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK373187D0 publication Critical patent/DK373187D0/da
Publication of DK373187A publication Critical patent/DK373187A/da
Application granted granted Critical
Publication of DK174931B1 publication Critical patent/DK174931B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198703731A 1986-07-18 1987-07-17 Lægemiddel med langsom frigivelse af den aktive bestanddel DK174931B1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (3)

Publication Number Publication Date
DK373187D0 DK373187D0 (da) 1987-07-17
DK373187A DK373187A (da) 1988-01-19
DK174931B1 true DK174931B1 (da) 2004-03-01

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703731A DK174931B1 (da) 1986-07-18 1987-07-17 Lægemiddel med langsom frigivelse af den aktive bestanddel

Country Status (13)

Country Link
US (1) US5030455A (el)
EP (1) EP0254978B1 (el)
JP (1) JPH0816066B2 (el)
KR (1) KR960004857B1 (el)
AT (1) ATE71291T1 (el)
CA (1) CA1309656C (el)
DE (1) DE3775850D1 (el)
DK (1) DK174931B1 (el)
ES (1) ES2040228T3 (el)
FI (1) FI96095C (el)
GR (1) GR3003536T3 (el)
NO (1) NO179163C (el)
PH (1) PH25286A (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
DK1473031T3 (da) * 1993-12-13 2008-10-20 Avanir Pharmaceuticals Sucroseester - C20 til C28 alkoholformuleringer
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
EP0873127B1 (en) * 1995-09-25 2006-11-15 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE69730218D1 (de) * 1996-04-11 2004-09-16 Univ British Columbia Fusogene liposomen
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
MXPA04003807A (es) * 2001-11-30 2004-07-30 Pfizer Prod Inc Formulaciones farmaceuticas de 5, 7, 14-trianzatetraciclo [10.3.1.02, 11, 04, 9]-hexadeca -2 (11), 3, 5, 7, 9-pentaeno.
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
CN103249510B (zh) * 2010-12-08 2016-05-18 会田工程技术有限公司 高强度烧结成形体的制造方法及其制造装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
EP0176772B1 (de) * 1984-08-30 1989-03-29 RODISMA Pharmazeutische Produkte GmbH Verfahren zur Retardierung von Vitamin C und E

Also Published As

Publication number Publication date
ATE71291T1 (de) 1992-01-15
ES2040228T3 (es) 1993-10-16
KR880001301A (ko) 1988-04-22
CA1309656C (en) 1992-11-03
FI873106A (fi) 1988-01-19
JPS6327439A (ja) 1988-02-05
NO872991D0 (no) 1987-07-17
DE3775850D1 (de) 1992-02-20
DK373187A (da) 1988-01-19
NO872991L (no) 1988-01-19
PH25286A (en) 1991-04-30
EP0254978B1 (en) 1992-01-08
FI96095B (fi) 1996-01-31
JPH0816066B2 (ja) 1996-02-21
US5030455A (en) 1991-07-09
FI96095C (fi) 1996-05-10
KR960004857B1 (ko) 1996-04-16
EP0254978A1 (en) 1988-02-03
GR3003536T3 (el) 1993-03-16
DK373187D0 (da) 1987-07-17
NO179163C (no) 1996-08-21
FI873106A0 (fi) 1987-07-14
NO179163B (no) 1996-05-13

Similar Documents

Publication Publication Date Title
DK174931B1 (da) Lægemiddel med langsom frigivelse af den aktive bestanddel
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
DK98088D0 (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
ES2054932T3 (es) Preparaciones de liberacion sostenida y proceso de las mismas.
ATE222759T1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DK583789A (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
DE3883756D1 (de) Haarkosmetisches Präparat.
ATE212235T1 (de) Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
DK386986D0 (da) Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel
DK189189D0 (da) Azelastinholdigt laegemiddel med kontrolleret frigivelse af det aktive stof
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
NO172188C (no) Fremstilling av pertussis-toksin ved dyrkning av bordetella pertussi
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
FR2625504B2 (fr) Derives de ((benzoyl-1 piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
DK202791A (da) Farmaceutisk praeparat med indhold af 3'-azido-3'-desoxythymidin som aktiv ingrediens samt 3'-azido-3'-desoxythymidin til anvendelse mod human retrovirusinfektion
ATE60578T1 (de) Prostacyclinanalog, dieses als aktives bestandteil enthaltendes, den blutumlauf verbesserndes mittel und gegen magengeschwuere wirkendes mittel.
FR2630113B2 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR2630114B2 (fr) Derives de (piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
PUP Patent expired